When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMA - ADMA Biologics: Another Quarter Of Progress And Another Dip To Buy
ADMA Biologics Inc
ADMA Biologics recently reported its Q3 earnings with a beat on EPS and revenue. In addition, the company reported encouraging commercial progress for its IVIG products despite the COVID-19 headwinds.
Unfortunately, the healthcare sector is experiencing some selling pressure after the outcome of the U.S. presidential election, and ADMA is moving closer to 52-week lows.
I intended to take advantage of the unjustified sell-off and will explain my reasoning for buying into the weakness.